Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial encephalomyopathies: what next?

S DiMauro1

  • 1H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Department of Neurology, Columbia-Presbyterian Medical Center, New York, NY, USA.

Journal of Inherited Metabolic Disease
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cerebellar ataxia and severe muscle CoQ10 deficiency in a patient with a novel mutation in ADCK3.

Clinical genetics·2016
Same author

Impact commentaries. Subacute necrotising encephalomyelopathy (Leigh's disease; Leigh syndrome).

Journal of neurology, neurosurgery, and psychiatry·2015
Same author

Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease?

Neurology·2012
Same author

Progress and problems in muscle glycogenoses.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology·2011
Same author

Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype.

Neurology·2011
Same author

Metabolic disorders of fetal life: glycogenoses and mitochondrial defects of the mitochondrial respiratory chain.

Seminars in fetal & neonatal medicine·2011
Same journal

Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I.

Journal of inherited metabolic disease·2026
Same journal

Immune Dysregulation in Branched Chain Organic Acidemias.

Journal of inherited metabolic disease·2026
Same journal

Long Term Follow-Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study.

Journal of inherited metabolic disease·2026
Same journal

Tri-Parametric Assessment of α-Galactosidase A Activity, lysoGb3 and X-Inactivation Aids Genotype-Phenotype Categorization of Fabry Disease Female Patients.

Journal of inherited metabolic disease·2026
Same journal

Mapping the Severity of Phenylalanine Hydroxylase Deficiency.

Journal of inherited metabolic disease·2026
Same journal

Gaucher Disease Treated With Lentiviral-Mediated Gene Therapy: First Case.

Journal of inherited metabolic disease·2026
See all related articles

Mitochondrial disease research shows remarkable progress, particularly in mitochondrial DNA (mtDNA) mutations. However, challenges remain in understanding nuclear DNA mutations, protein import, intergenomic signaling, and developing effective therapies and genetic counseling for these complex disorders.

Area of Science:

  • Mitochondrial Medicine
  • Genetics
  • Molecular Biology

Background:

  • Mitochondrial diseases, particularly those linked to mitochondrial DNA (mtDNA) mutations, have seen significant advancements.
  • Despite progress, several research areas require further investigation and clarification.

Purpose of the Study:

  • To review areas of limited progress and controversial data in mitochondrial disease research.
  • To highlight key challenges in understanding the molecular basis and pathophysiology of these disorders.
  • To discuss the implications for aging, neurodegenerative diseases, therapy, and genetic counseling.

Main Methods:

  • Literature review of current research on mitochondrial diseases.
  • Analysis of controversial findings and areas with limited data.

Related Experiment Videos

  • Synthesis of information on genetic and molecular aspects of mitochondrial disorders.

    • Main Results:

    • Progress in understanding nuclear DNA mutations affecting the respiratory chain is limited.
    • Defects in mitochondrial protein importation and intergenomic signaling present complex challenges.
    • The pathophysiology of mtDNA-related disorders, their link to aging, and therapeutic strategies require further elucidation.

    Conclusions:

    • Significant challenges persist in understanding and treating mitochondrial diseases.
    • Further research is crucial for advancing therapeutic options and genetic counseling.
    • Addressing these complex areas is vital for improving patient outcomes.